Forbes has launched ForbesPredict, a moneyless prediction platform developed with Axiom, where users build profiles by logging predictions on real-world events without trading currency. The platform aims to deepen audience engagement as Forbes shifts away from traffic-based metrics towards loyalty and participation. Unlike mainstream prediction platforms such as Kalshi, ForbesPredict requires users to digest and interpret news coverage to make informed predictions, creating a record of correct and incorrect forecasts. "AI is fundamentally changing how people access information," said Nina Gould, Forbes' chief innovation officer. "Our response isn't to chase scale, but to deepen engagement." The platform will provide Forbes with insights into audience preferences whilst encouraging users to return and participate rather than simply consume headlines. Forbes maintains its readers seek information, not speculation.

Newsletter Signup - Under Article / In Page"*" indicates required fields CRISPR-Cas9 is one of the biggest discoveries of the 21st century. Since it was developed in 2012, this gene-editing tool has revolutionized biology research, making it easier to study disease and faster to discover drugs. The technology is also significantly impacting the development of crops, foods, and industrial fermentation processes.The one application that has made it famous is the modification of the human genome, which brings the promise of using CRISPR to cure diseases. Since 2012, a lot has happened and drug candidates have progressed so far that one has even reached approval. So while scientists keep venturing into tweaking our DNA, it is worth taking the time to fully understand what CRISPR is, and what the actual benefits and possibilities are.First of all, what is CRISPR-Cas9?CRISPR is short for ‘clustered regularly interspaced short palindromic repeats.’ The term refers to a series of repetitive patterns in the DNA of bacteria and archaea that were extensively researched by Spanish scientist Francis Mojica in the ‘90s. These patterns are the basis of a primitive immune system that bacteria use to ‘remember’ the DNA of viral invaders by incorporating the DNA sequence of the virus within the CRISPR patterns. The Cas9 protein is then able to recognize the DNA sequence stored within CRISPR patterns and cut any DNA molecules with a matching sequence.But it wasn’t until 2012 that Jennifer Doudna and Emmanuelle Charpentier took the discovery a step further and proposed that CRISPR-Cas9 could be used to cut any desired DNA sequence by just providing it with the right template